About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration

NCT03303391·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Texas Southwestern Medical Center

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age greater than 18 years
End Stage Renal Disease on Maintenance Hemodialysis
Hypertension defined as systolic blood pressure \> 140 mmHg pre-dialysis or \>130 mmHg post dialysis

You may not be if

Hemodialysis Vintage \< 1 month
Pregnancy
Nadir Systolic Blood Pressure \< 95 mmHg
Pre or Post dialysis systolic blood pressure \> 180 mmHg
Decrease in systolic blood pressure \>60 mmHg from pre to post dialysis
Ultrafiltration rate \>13 mL/kg/hr
Peridialytic Midodrine Use
Intradialytic Clonidine use
Documented Antihypertensive Medication Non-adherence
Bioimpedance will not be peformed on patients with
amputated arms or legs
cardiac defibrillator or pacemaker
presence of metal prostheses

The record

StatusTerminated

PhaseNo phase

Taking part14

StartedNov 2017

UpdatedAug 25, 2022

Conditions

ESRD Extracellular Fluid Alteration Hypertension

Where1

Davita Dialysis
Dallas, Texas, United States

Clareo Health | Using Intradialytic Blood Pressure Slopes to Guide Ultrafiltration